Hypersensitivity reactions to non-betalactam antibiotics in children: an extensive review

Semanur Kuyucu1, Francesca Mori, Marina Atanaskovic-Markovic

  • 1Department of Pediatric Allergy and Immunology, Mersin University, Faculty of Medicine, Mersin, Turkey.

Insights

Hypersensitivity reactions (HSRs) to non-β-lactam antibiotics (NBLAs) in children are poorly understood, with limited diagnostic tools. Standardized approaches are needed for evaluating these critical reactions.

Area of Science:

  • Pediatric Allergy and Immunology
  • Pharmacology and Therapeutics

Background:

  • Hypersensitivity reactions (HSRs) to non-β-lactam antibiotics (NBLAs) in children are under-researched, with data primarily from case reports.
  • NBLAs can cause a broad range of HSRs, from mild rashes to severe, potentially fatal systemic reactions, particularly in high-risk pediatric populations.

Purpose of the Study:

  • To review and synthesize current knowledge on the clinical characteristics, diagnostic evaluation, and management of HSRs to NBLAs in children.
  • To highlight the challenges in diagnosing NBLA hypersensitivity due to limitations in current testing methodologies.

Main Methods:

  • Extensive literature review of studies published between 1980 and 2013.
  • Analysis of clinical characteristics, diagnostic approaches (history, skin tests, provocation tests), and management strategies for NBLA-induced HSRs in pediatric patients.

Main Results:

  • Diagnosis of NBLA-induced HSRs heavily relies on patient history, as allergological tests often remain unconfirmed.
  • Validated in vivo and in vitro diagnostic tests for NBLAs are lacking, making definitive diagnosis challenging.
  • Confirmed HSRs to NBLAs in children ranged from 7.8% to 36% when assessed by skin and/or provocation tests.

Conclusions:

  • A significant proportion of suspected HSRs to NBLAs in children are not confirmed by objective testing.
  • There is a critical need for standardized diagnostic approaches and management strategies for pediatric patients experiencing suspected HSRs to NBLAs.
  • Developing such strategies is essential, especially given the importance of some NBLAs in pediatric treatment regimens.

Related Concept Videos

Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...